ArticleJournal of experimental & clinical cancer research : CR2021

Regorafenib enhances anti-PD1 immunotherapy efficacy in murine colorectal cancers and their combination prevents tumor regrowth.

Dennis Doleschel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.